Two Sigma Investments
HUMAW icon

Two Sigma Investments’s Humacyte Inc Warrant HUMAW Stock Holding History

Two Sigma Investments’s Portfolio HUMAW Stock Details HUMAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-55,767
Closed -$77.5K – 3215
2024
Q2 		$77.5K Buy
55,767
+34,118
+158% +$42.3K ﹤0.01% 2848
2024
Q1 		$13K Buy
+21,649
New +$13.4K ﹤0.01% 2944

Other funds holding HUMAW

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Two Sigma Investments's HUMAW Position: Q3 2024 in Review

Two Sigma Investments sold out of Humacyte Inc Warrant (HUMAW) in Q3 2024, closing a stake of 55,767 shares — an estimated $77.5K sold.

Two Sigma Investments first reported a position in HUMAW in Q1 2024 and held it in 2 quarters. The position peaked at $77.5K in Q2 2024. 7 funds tracked by Wall St. Rank hold HUMAW as of Q3 2024.

  • Two Sigma Investments reported no remaining Humacyte Inc Warrant position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Investments sold 55,767 Humacyte Inc Warrant shares in Q3 2024, an estimated $77.5K.
  • Two Sigma Investments first reported a position in Humacyte Inc Warrant in Q1 2024 and held it in 2 quarters.
  • Two Sigma Investments's Humacyte Inc Warrant position peaked at $77.5K in Q2 2024.
  • 7 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q3 2024.

Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.